Arcadia Biosciences
Financial ratios & Valuation

Forward Multiples (2025 – 2026)

20252026
Price/Earnings ratio
-2.47-1.62
Price/Sales ratio
15.4813.37
Earnings per Share (EPS)
$-1.80$-2.74

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-13.02-4.83-2.07-0.75-0.88-1.20-4.18-1.37-0.41-0.27-0.18-0.88
Price/Sales ratio
34.2116.0312.802.948.1529.823.133.260.650.720.2429.82
Price/Book Value ratio
-126.712.151.831.480.934.520.900.710.300.300.204.52
Price/Cash Flow ratio
-16.15-5.74-2.39-0.84-0.87-2.02-0.83-0.85-0.46-0.25-0.19-0.87
Price/Free Cash Flow ratio
-15.99-5.68-2.36-0.84-0.86-1.86-0.77-0.82-0.46-0.25-0.19-0.86
Price/Earnings Growth ratio
-0.33-0.390.070.040.01-0.040.04-0.050.020.00-0.00-0.00
Dividend Yield
N/A0.22%N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
71.39%83.52%71.92%92.97%54.84%24.29%35.28%-28.43%1.54%38.08%1.91%24.29%
Operating Profit Margin
-217.02%-287.45%-584.06%-355.56%-1152.32%-1743.45%-268.75%-523.98%-194.88%-261.50%-159.80%-1152.32%
Pretax Profit Margin
-245.54%-331.17%-614.77%-389.49%-920.08%-2469.71%-76.54%-237.93%-156.66%-246.84%-140.92%-920.08%
Net Profit Margin
-262.66%-331.65%-615.55%-390.13%-920.76%-2469.88%-75.00%-237.96%-156.81%-262.30%-138.78%-920.76%
Effective Tax Rate
-1.53%-0.14%-0.12%-0.16%-0.07%-0.00%2.01%-0.01%-0.08%-0.06%0.02%-0.07%
Return on Assets
-73.68%-24.18%-34.68%-94.79%-56.11%-88.63%-12.72%-36.73%-53.97%-70.95%-81.74%-88.63%
Return On Equity
972.89%-44.63%-88.40%-196.16%-105.18%-374.73%-21.73%-51.88%-74.22%-108.87%-91.65%-105.18%
Return on Capital Employed
-111.25%-21.98%-34.83%-109.73%-80.44%-75.86%-52.61%-91.37%-78.51%-86.49%-110.14%-75.86%
Liquidity Ratios
Current Ratio
N/A15.0716.684.267.494.985.01N/AN/AN/A6.034.98
Quick Ratio
1.6214.9916.604.207.434.664.416.145.423.625.214.66
Cash ratio
1.476.940.642.583.921.472.225.694.901.814.903.92
Days of Sales Outstanding
74.3353.1261.02111.9641.88187.9663.8773.7544.7635.1927.57187.96
Days of Inventory outstanding
77.49120.30102.77295.3599.94739.89267.62185.8195.73216.5656.16739.89
Operating Cycle
151.83173.42163.79407.31141.83927.86331.50259.56140.50251.7662.96927.86
Days of Payables Outstanding
44.59173.4990.53472.04157.37202.9150.9659.1433.6988.5962.94202.91
Cash Conversion Cycle
107.23-0.0673.25-64.73-15.54724.94280.53200.42106.80163.17-21.51724.94
Debt Ratios
Debt Ratio
0.580.330.44N/AN/A0.020.080.020.030.040.270.27
Debt Equity Ratio
-7.670.611.13N/AN/A0.090.140.030.040.060.380.38
Long-term Debt to Capitalization
1.260.380.53N/AN/A0.010.07N/AN/AN/A0.040.01
Total Debt to Capitalization
1.140.380.53N/AN/A0.080.120.030.040.060.080.08
Interest Coverage Ratio
N/A-5.85-14.11-19.16N/A-4.07K-459.40N/AN/AN/A-85.06-4.07K
Cash Flow to Debt Ratio
-1.02-0.60-0.67N/AN/A-23.17-7.62-24.08-13.83-17.95-11.01-11.01
Company Equity Multiplier
-13.201.842.542.061.874.221.701.411.371.531.374.22
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-2.11-2.79-5.34-3.46-9.31-14.71-3.76-3.81-1.40-2.86-1.30-9.31
Free Cash Flow / Operating Cash Flow Ratio
1.011.001.011.001.011.081.071.031.001.001.001.08
Cash Flow Coverage Ratio
-1.02-0.60-0.67N/AN/A-23.17-7.62-24.08-13.83-17.95-11.01-11.01
Short Term Coverage Ratio
-2.63N/AN/AN/AN/A-27.08-16.26-24.08-13.83-17.95-22.00-22.00
Dividend Payout Ratio
N/A-1.09%N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A